Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

BHST vs JBSS: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

JBSS Wins Head-to-Head Institutional Verdict (4–2 across 6 Pillars · 8–2 Matrix Metrics)

JBSS Overall Winner 6-Pillar Tally: BHST 2 – 4 JBSS Matrix Metrics: BHST 2 – 8 JBSS

As of Nov 20, 2026, John B. Sanfilippo & SON (JBSS) is the stronger overall head-to-head candidate over BioHarvest Sciences Inc. (BHST) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). BHST carries a Unified Composite Score of 58.2/100 (HOLD) at $1.30 (N/M Forward P/E, -18.0% operating margin), whereas JBSS carries 47.3/100 (HOLD) at $61.07 (10.1x Forward P/E, 6.7% operating margin).

  • Composite vs. Pillar Nuance: While BHST currently prints a higher short-term Unified Composite Score (58.2/100 HOLD vs. JBSS 47.3/100 HOLD), JBSS captures the overall institutional head-to-head verdict (8–2 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (6.7% vs. -18.0% operating margin) and revenue trajectory (-3.5% vs. +3.8% YoY).
  • Technical & Structure Timing Caution: BHST is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 37.2); meanwhile JBSS is in a Breakdown options structure phase (RSI 50.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About BHST vs JBSS
BHST NASDAQ
BioHarvest Sciences Inc. Common Stock
Pharmaceutical Preparations
$1.30
-1.52% 1D
Market Cap $29.9M
TTM Revenue $35M
Forward P/E N/M
Beta / 30D Vol 0.25β · 86% Vol
Unified Composite Score
58.2 / 100 HOLD
Tech 75.0 Fund 57.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -9.1%), weak momentum, RSI 37
RSI-14: 37.2 · SMA20: $1.55 · SMA50: $1.58
JBSS NASDAQ Head-to-Head Winner
John B. Sanfilippo & SON
Sugar & Confectionery Products
$61.07
+0.49% 1D
Market Cap $710.6M
TTM Revenue $1.17B
Forward P/E 10.1x
Beta / 30D Vol 0.21β · 62% Vol
Unified Composite Score
47.3 / 100 HOLD
Tech 53.0 Fund 55.0 Flow 62.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 51
RSI-14: 50.6 · SMA20: $58.58 · SMA50: $63.81

6-Pillar Scorecard Institutional Category Breakdown (BHST 2 – 4 JBSS)

Columns: Metric · BHST · JBSS
1. Valuation Multiples JBSS
Forward P/E N/M 10.1x
Trailing P/E N/M 12.7x
PEG Ratio N/M 1.52x
EV / Revenue 0.7x 0.7x
2. Growth & Scale BHST
Revenue Growth (YoY) +3.8% -3.5%
Earnings Growth (YoY) +0.0% -30.2%
TTM Revenue (USD) $35M $1.17B
Market Cap $29.9M $710.6M
3. Profitability & Quality JBSS
Gross Margin 59.0% 17.7%
Operating Margin -18.0% 6.7%
Net Profit Margin -31.2% 4.8%
Return on Equity (ROE) -142.5% 15.4%
4. Balance Sheet & Cash Flow JBSS
Cash Generation (TTM) -$9.4M $30M
Cash Flow Margin -26.6% 2.6%
Net Cash / Leverage $5.1M Net Cash $140M Net Debt (0.38x D/E)
Dividend Yield None (0.00%) 1.55%
5. Options & Positioning JBSS
Options Structure Phase UNCLASSIFIED BREAKDOWN
Current IV / %ile N/A (N/A) 92.9% (18th %ile)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markdown ACCUMULATION · Neutral
6. R&D & Supply-Chain Moat BHST
OpEx & R&D Intensity 77.0% of Rev ($27M) 11.0% of Rev ($128M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Packaged Foods Operator Packaged Foods Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: BHST (2) vs JBSS (8)
Institutional Metric BHST JBSS Criterion Row Edge
Market Capitalization
Scale
$29.9M $710.6M Larger Scale JBSS
Trailing P/E Ratio
Valuation
N/M 12.7x Lower Multiple JBSS
Forward P/E Ratio
Valuation
N/M 10.1x Lower Multiple JBSS
Revenue Growth (YoY)
Growth
+3.8% -3.5% Higher Growth BHST
Operating Margin (TTM)
Profitability
-18.0% 6.7% Higher Margin JBSS
Net Profit Margin
Profitability
-31.2% 4.8% Higher Margin JBSS
Return on Equity (ROE)
Capital Efficiency
-142.5% 15.4% Higher ROE JBSS
52-Week Range Position
Momentum
6% ($1–$7) 25% ($51–$92) Stronger Trend JBSS
Beta / 30D Volatility
Risk Regime
0.25β · 86% Vol 0.21β · 62% Vol Lower Realized Risk JBSS
Unified Institutional Score
Composite Signal
58.2 / 100 (HOLD) 47.3 / 100 (HOLD) Higher Composite BHST
Trailing 12M Revenue (USD)
Operating Scale
$35M $1.17B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
59.0% 17.7% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 0.7x EV/Rev 1.52x PEG · 0.7x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$9.4M ($5.1M Net Cash) $30M ($140M Net Debt (0.38x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon JBSS +12.07 pp
BHST: -22.62% · JBSS: -10.55%
3M Horizon JBSS +17.49 pp
BHST: -36.59% · JBSS: -19.1%
6M Horizon JBSS +45.93 pp
BHST: -66.32% · JBSS: -20.39%
1Y Horizon JBSS +68.04 pp
BHST: -79.4% · JBSS: -11.36%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period BHST Revenue JBSS Revenue BHST Op. Margin JBSS Op. Margin Margin Leader
FY2019 N/A $880M N/A 6.7% JBSS
FY2020 N/A $880M N/A 8.9% JBSS
FY2021 N/A $860M N/A 9.9% JBSS
FY2022 N/A $960M N/A 9.1% JBSS
FY2023 $10M $1.00B -78.6% 9.0% JBSS
FY2024 $30M $1.07B -27.7% 8.0% JBSS
FY2025 $30M $1.11B -16.2% 7.7% JBSS
FY2026 N/A $1.18B N/A 7.6% JBSS

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
BHST UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact BHST Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
JBSS BREAKDOWN
99d in phase · OBV ACCUMULATION
Current IV 92.9%
IV Percentile 18th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow ACCUMULATION
Exact JBSS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
BHST Moat Profile Cyclical / Execution-Driven Positioning
Packaged Foods Operator
Competes within the Packaged Foods value chain with $29.9M market capitalization and -18.0% operating margin.
OpEx & R&D Reinvestment 77.0% of Rev ($27M)
90D Engineering Disclosures 0 Published
JBSS Moat Profile Cyclical / Execution-Driven Positioning
Packaged Foods Operator
Competes within the Packaged Foods value chain with $710.6M market capitalization and 6.7% operating margin.
OpEx & R&D Reinvestment 11.0% of Rev ($128M)
90D Engineering Disclosures 0 Published

Investor FAQ BHST vs JBSS Key Questions & Quantitative Answers

As of Nov 20, 2026, John B. Sanfilippo & SON (JBSS) is the stronger overall head-to-head candidate over BioHarvest Sciences Inc. (BHST) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). BHST carries a Unified Composite Score of 58.2/100 (HOLD) at $1.30 (N/M Forward P/E, -18.0% operating margin), whereas JBSS carries 47.3/100 (HOLD) at $61.07 (10.1x Forward P/E, 6.7% operating margin). Composite vs. Pillar Nuance: While BHST currently prints a higher short-term Unified Composite Score (58.2/100 HOLD vs. JBSS 47.3/100 HOLD), JBSS captures the overall institutional head-to-head verdict (8–2 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (6.7% vs. -18.0% operating margin) and revenue trajectory (-3.5% vs. +3.8% YoY). Technical & Structure Timing Caution: BHST is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 37.2); meanwhile JBSS is in a Breakdown options structure phase (RSI 50.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

BHST leads the Growth & Scale pillar: BHST posts +3.8% YoY revenue growth and +0.0% YoY earnings growth on $35M TTM revenue (59.0% gross margin, -18.0% operating margin), compared with JBSS at -3.5% YoY revenue growth and -30.2% YoY earnings growth on $1.17B TTM revenue (17.7% gross margin, 6.7% operating margin). Across the 8-period historical trajectory (FY2019 to FY2026), BHST cumulative revenue shifted +200.0% while JBSS shifted +34.1%. In operating R&D and SG&A reinvestment, BHST deploys 77.0% of Rev ($27M) (0 90-day corporate R&D disclosures) versus 11.0% of Rev ($128M) (0 disclosures) for JBSS.

JBSS screens cheaper on headline valuation multiples. BHST trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.7x EV/Revenue (-26.6% FCF margin), whereas JBSS trades at 10.1x Forward P/E, 12.7x Trailing P/E, 1.52x PEG, and 0.7x EV/Revenue (2.6% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against BHST (-142.5% ROE) versus JBSS (15.4% ROE) capital efficiency.

In options market volatility and institutional positioning, BHST carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.25β · 86% Vol realized risk). By comparison, JBSS carries 92.9% implied volatility (18th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, ACCUMULATION on-balance volume, and sits in a BREAKDOWN options structure phase (0.21β · 62% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.